medmix AG (SWX:MEDX)

Market Cap	402.58M +10.3%
Revenue (ttm)	437.00M -6.6%
Net Income	100.00K
EPS	-0.00
Shares Out	40.71M
PE Ratio	4,025.84
Forward PE	19.51
Dividend	0.10 (1.01%)
Ex-Dividend Date	Apr 20, 2026

Volume	38,021
Open	9.78
Previous Close	9.83
Day's Range	9.76 - 9.96
52-Week Range	7.61 - 12.36
Beta	0.83
Analysts	Strong Buy
Price Target	14.97 (+51.37%)
Earnings Date	Feb 25, 2027

About medmix AG

medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through the Healthcare, and Consumer and Industrial segments. The company offers dispensers, cartridges, mixers, tips, syringes, pen, and auto injectors for delivery of dental materials; delivery devices and mixing for bone repair and tissue treatment, which are used for prosthetics, restoratives, anesthetics, and aesthetics; the pen and auto injectors, which are used in fertility and growth hormone treatments, treatment of...

• Industry: Specialty Industrial Machinery
• Sector: Industrials
• Founded: 1922
• Employees: 2,587
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: MEDX

Analyst Summary

According to 3 analysts, the average rating for MEDX stock is "Strong Buy." The 12-month stock price target is CHF 14.97, which is an increase of 51.37% from the latest price.

Price Target

CHF 14.97

(51.37% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 2, 2026

Data Sources Report a data error